Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Increasing sputum levels of gamma-glutamyltransferase may identify cystic fibrosis patients who do not benefit from inhaled glutathione.

Increasing sputum levels of gamma-glutamyltransferase may identify cystic fibrosis patients who do not benefit from inhaled glutathione.

Resource Type

CF Research News

Authors

Corti A, Griese M, Hector A, Pompella A

References

J Cyst Fibros. 2016 Dec 14. pii: S1569-1993(16)30671-3.

Document

PDF icon CF Research News article [1]

Link

Scientific abstract [2]

Keywords

Gamma-glutamyltransferase [3]
Glutathione [4]
Inflammation [5]

Date

Wednesday, December 14, 2016

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/increasing-sputum-levels-gamma-glutamyltransferase-may-identify

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/1002a_corti.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=INCREASING%20SPUTUM%20LEVELS%20OF%20GAMMA-GLUTAMYLTRANSFERASE%20MAY%20IDENTIFY%20CYSTIC%20FIBROSIS%20PATIENTS%20WHO%20DO%20NOT%20BENEFIT%20FROM%20INHALED%20GLUTATHIONE [3] https://www.ecfs.eu/research-article-keywords/gamma-glutamyltransferase [4] https://www.ecfs.eu/research-article-keywords/glutathione [5] https://www.ecfs.eu/research-article-keywords/inflammation [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines